0.4788
전일 마감가:
$0.4682
열려 있는:
$0.4702
하루 거래량:
768.45K
Relative Volume:
0.83
시가총액:
$41.36M
수익:
$2.24M
순이익/손실:
$-136.67M
주가수익비율:
-0.2091
EPS:
-2.29
순현금흐름:
$-102.08M
1주 성능:
-4.26%
1개월 성능:
-15.24%
6개월 성능:
-20.87%
1년 성능:
-69.89%
Century Therapeutics Inc Stock (IPSC) Company Profile
명칭
Century Therapeutics Inc
전화
215-981-4000
주소
25 N 38TH STREET, 11TH FLOOR, PHILADELPHIA
IPSC을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
IPSC
Century Therapeutics Inc
|
0.4788 | 41.10M | 2.24M | -136.67M | -102.08M | -2.29 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Century Therapeutics Inc Stock (IPSC) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-08-08 | 개시 | Rodman & Renshaw | Buy |
2023-08-28 | 다운그레이드 | JP Morgan | Overweight → Neutral |
2022-12-27 | 개시 | Chardan Capital Markets | Buy |
2022-10-31 | 개시 | Guggenheim | Buy |
2022-10-10 | 개시 | Canaccord Genuity | Buy |
2022-05-23 | 개시 | H.C. Wainwright | Buy |
2022-05-12 | 개시 | William Blair | Mkt Perform |
2021-07-13 | 개시 | BofA Securities | Buy |
2021-07-13 | 개시 | JP Morgan | Overweight |
2021-07-13 | 개시 | Piper Sandler | Overweight |
모두보기
Century Therapeutics Inc 주식(IPSC)의 최신 뉴스
Is Century Therapeutics Inc. stock bottoming outMarket Trend Report & Growth Oriented Trading Recommendations - Newser
Detecting price anomalies in Century Therapeutics Inc. with AIWeekly Stock Analysis & Risk Managed Investment Strategies - Newser
Understanding Century Therapeutics Inc.’s price movementRate Hike & Technical Confirmation Trade Alerts - Newser
What data driven models say about Century Therapeutics Inc.’s futureJuly 2025 Review & Entry Point Confirmation Alerts - Newser
Is a relief rally coming for Century Therapeutics Inc. holders2025 Fundamental Recap & Safe Swing Trade Setup Alerts - Newser
Analyzing Century Therapeutics Inc. with risk reward ratio chartsMarket Performance Report & Growth Focused Investment Plans - Newser
How moving averages guide Century Therapeutics Inc. tradingJuly 2025 Price Swings & Daily Chart Pattern Signal Reports - Newser
Reversal indicators forming on Century Therapeutics Inc. stockMarket Risk Report & Weekly High Return Stock Opportunities - Newser
What is the long term forecast for Century Therapeutics Inc. stock2025 Geopolitical Influence & Technical Pattern Recognition Alerts - khodrobank.com
Should you wait for a breakout in Century Therapeutics Inc.Weekly Loss Report & Free Fast Gain Swing Trade Alerts - Newser
Can Century Therapeutics Inc. ride the EV waveWeekly Stock Analysis & Weekly Breakout Stock Alerts - khodrobank.com
Sentiment Review: Can Century Therapeutics Inc. expand its profit margins2025 Market Trends & Community Consensus Trade Signals - khodrobank.com
Century Therapeutics shares rise 1.89% premarket after Fractyl Health expands its board of directors. - AInvest
Can Century Therapeutics Inc. rally from current levels2025 Year in Review & Stepwise Trade Signal Guides - Newser
What high frequency data says about Century Therapeutics Inc.July 2025 Trade Ideas & Technical Entry and Exit Alerts - Newser
Applying Elliott Wave Theory to Century Therapeutics Inc.Portfolio Update Summary & Advanced Swing Trade Entry Plans - Newser
Using fundamentals and technicals on Century Therapeutics Inc.Earnings Risk Report & Safe Entry Zone Identification - Newser
Is Century Therapeutics Inc. showing insider buyingJuly 2025 Highlights & Weekly High Return Opportunities - khodrobank.com
What earnings revisions data tells us about Century Therapeutics Inc.Weekly Earnings Recap & AI Powered Buy/Sell Recommendations - Newser
Using portfolio simulators with Century Therapeutics Inc. includedJuly 2025 Snapshot & AI Powered Trade Plan Recommendations - Newser
How hedge fund analytics apply to Century Therapeutics Inc. stockProfit Target & Fast Gain Swing Trade Alerts - Newser
Price action breakdown for Century Therapeutics Inc.July 2025 Summary & Community Verified Swing Trade Signals - Newser
Will Century Therapeutics Inc. outperform tech stocksDip Buying & AI Optimized Trading Strategy Guides - khodrobank.com
Is Century Therapeutics Inc. undervalued by DCF analysis2025 Year in Review & Verified Technical Signals - khodrobank.com
Century Therapeutics Inc. Added to Custom Quant Screener Today getLinesFromResByArray error: size == 0 - 강소기업뉴스
Can Century Therapeutics Inc. expand its profit marginsEarnings Recap Report & Precise Trade Entry Recommendations - khodrobank.com
Using Ichimoku Cloud for Century Therapeutics Inc. technicalsMarket Movement Recap & Risk Controlled Stock Alerts - Newser
Earnings visualization tools for Century Therapeutics Inc.Weekly Gains Summary & Weekly Breakout Stock Alerts - Newser
What makes Century Therapeutics Inc. stock price move sharply2025 Technical Patterns & Risk Managed Investment Signals - Newser
Technical analysis overview for Century Therapeutics Inc. stockJuly 2025 Technicals & Smart Allocation Stock Tips - Newser
Century Therapeutics Granted Nasdaq Compliance Extension - TipRanks
Century Therapeutics Inc (IPSC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Century Therapeutics Inc 주식 (IPSC) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
Carr Douglas | SVP Finance & Operations |
Aug 04 '25 |
Sale |
0.53 |
296 |
158 |
405,686 |
Carr Douglas | SVP Finance & Operations |
Jun 09 '25 |
Sale |
0.62 |
4,904 |
3,050 |
405,982 |
Farid Adrienne | Chief Operations Officer |
Jun 09 '25 |
Sale |
0.62 |
552 |
343 |
250,141 |
Pfeiffenberger Brent | President and CEO |
Jun 09 '25 |
Sale |
0.62 |
475 |
295 |
1,681,783 |
Russotti Gregory | See Remarks |
Jun 09 '25 |
Sale |
0.62 |
526 |
327 |
392,047 |
자본화:
|
볼륨(24시간):